Net Worth 2019: $7.6 Billion
At 63, Sanghvi, the founder of India's most valuable pharma outfit, Sun Pharma has a net worth of around $7.5 billion.
Sun Pharma which manufactures gynecology and oncology medicines amongst others, is one of India’s most companies with a revenue of $3.6 billion. It has operations across 150 countries and employs over 50,000 people.
Net Worth 2018: $12.8 Billion
In 2015, Dilip Sanghvi dethroned Mukesh Ambani, to become India's richest person. The wealth of Sun Pharma promoters was then at $19 billion. However, over the last four years, Shanghvi lost over 60% of his wealth owing to declining Sun Pharma valuation. Sun Pharma’s market cap declined more than 40% between 2015 and 2018 after US Food and Drug Administration issued a warning against Sun Pharma’s Halol plant over manufacturing lapses. According to Forbes, he had a net worth of $16.7 Billion in 2016, which reduced to $7.6 billion in 2019.
Net Worth 2016: $16.7 Billion
Interestingly, he also took home a salary of merely ₹1 in FY 2019 to reduce operational costs of Sun Pharma -- a 99% cut from his usual salary of ₹3 crore.
Net Worth 2015: $20 Billion
Shanghvi never studied science or management and worked at a tiny shop in Dawa Bazar in Calcutta. He came from a middle class family in Amreli, Gujarat and pursued Bachelor of Commerce from the University of Calcutta.
He worked as a pharmaceutical distributor and later started his own company at the age of 27. He took a ₹10,000 loan from his father, and two medicines for psychiatry to start the company.
Credits: Sun Pharma
Net Worth 2013: $12.8 Billion
Shanghvi zealously guards his privacy, According to Soma Das, the only writer to write his biography says, he is among the least documented people in India because he is unwilling to share his story.
However, one of his quotes made it to Forbes which said, Our story is all about incremental growth. We're not looking for big leaps; we prefer small jumps.
Copyright © 2023. Times Internet Limited. All rights reserved.For reprint rights. Times Syndication Service.